Registry to Gather Long-time Results After Surgical Aortic Valve Replacement With a "Rapid Deployment Aortic Valve Prothesis (Edwards Intuity) Combined With Bypss Surgery (CABG)
NCT ID: NCT03326778
Last Updated: 2021-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
220 participants
OBSERVATIONAL
2017-11-26
2020-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Registry to Evaluate the Impact of a Valve Coordinator on Aortic Stenosis / TAVI Outcome - (German Pilot)
NCT03570190
Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alternative Access
NCT03056573
EDWARDS INTUITY Valve System FOUNDATION Study
NCT02338154
The ReTAVI Prospective Observational Registry
NCT05601453
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
NCT06777368
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The advantage of rapid deployment aortic valve prostheses, like the Edward Intuity Elite Valve that is used in this registry, is the greater ease of implantation, because only a few sutures are necessary to secure the device compared to a conventional prosthesis, where more then ten sutures are needed. In procedures where the aortic valve replacement (AVR) is combined with a coronary artery bypass graft (CABG), the use of a rapid deployment valve can shorten the duration of cardiac ischemia and the overall intervention duration, which possibly has an influence on clinical results.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AVR + CABG
Patient receiving AVR combined with CABG
AVR and CABG
Combined AVR with CABG
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AVR and CABG
Combined AVR with CABG
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients in who the Edwards Intuity Elite valve is to be implanted
* patients who are planned to receive at least one coronary bypass
* patients who have signed an informed consent form
Exclusion Criteria
* re-operation (i.e. any previous opening of pericardium)
* additional heart diseases requiring heart surgery (e. g. subvalvular myectomy and ablation, but not atrial auricle closure or resection)
* legal incapacity or other circumstances that impair the patient's ability to understand the nature, meaning or extent of the trial
* patients wanting a mechanical prosthesis
* patients with contraindications for the Edwards Intuity Elite Valve
* acute endocarditis or other systemic infections
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Edwards Lifesciences
INDUSTRY
Software for Trials Europe GmbH
UNKNOWN
Institut für Pharmakologie und Präventive Medizin
NETWORK
Campus Bad Neustadt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anno Diegeler, Prof.
Role: PRINCIPAL_INVESTIGATOR
Campus Bad Neustadt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Campus Bad Neustadt
Bad Neustadt an der Saale, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INCA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.